D
Phathom Pharmaceuticals, Inc. PHAT
$4.41 $0.194.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 29.66M 16.35M 7.32M 1.91M 682.00K
Total Other Revenue -- -- -- -- --
Total Revenue 29.66M 16.35M 7.32M 1.91M 682.00K
Cost of Revenue 3.82M 2.36M 1.38M 426.00K 167.00K
Gross Profit 25.85M 14.00M 5.95M 1.49M 515.00K
SG&A Expenses 76.68M 76.10M 75.87M 62.01M 57.00M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 89.08M 87.15M 84.62M 71.87M 70.56M
Operating Income -59.42M -70.80M -77.30M -69.95M -69.88M
Income Before Tax -74.45M -85.58M -91.45M -82.85M -79.57M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -74.45M -85.58M -91.45M -82.85M -79.57M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -74.45M -85.58M -91.45M -82.85M -79.57M
EBIT -59.42M -70.80M -77.30M -69.95M -69.88M
EBITDA -59.22M -70.61M -77.10M -69.74M -69.69M
EPS Basic -1.05 -1.32 -1.56 -1.42 -1.39
Normalized Basic EPS -0.66 -0.83 -0.98 -0.89 -0.87
EPS Diluted -1.05 -1.32 -1.56 -1.42 -1.39
Normalized Diluted EPS -0.66 -0.83 -0.98 -0.89 -0.87
Average Basic Shares Outstanding 71.04M 64.63M 58.56M 58.37M 57.29M
Average Diluted Shares Outstanding 71.04M 64.63M 58.56M 58.37M 57.29M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings